Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition.
Preprint
- 14 February 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Endometrial cancer (EC) patients with metastatic/recurrent disease have limited treatment options and poor survival outcomes. Recently, we discovered the FGFR2c isoform is associated with poor prognosis in EC patients. Here we report the establishment of 14 EC patient-derived xenografts (PDX)-derived organoids (PDXOs) with or without FGFR2c expression. Treatment of 5 EC PDXOs with BGJ398 showed significant cell death in 3 models with FGFR2c expression. PDXs with FGFR2c+ showed significant tumour growth inhibition (TGI) following 21-day treatment with FGFR inhibitors (BGJ398 or pemigatinib) and significantly prolonged survival in 4/5 models. Pemigatinib + cisplatin combination therapy (n=5) resulted in significant TGI and prolonged survival in one of two p53abn PDXs. All five models treated with cisplatin alone showed de novo resistance and no survival benefit. Seven-day treatment with BGJ398 revealed a significant reduction in angiogenesis and CD206+ M2 macrophages. This data collectively supports the evaluation of FGFR inhibitors in a clinical trial.Keywords
All Related Versions
This publication has 45 references indexed in Scilit:
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Sustained Levels of FGF2 Maintain Undifferentiated Stem Cell Cultures with Biweekly FeedingPLOS ONE, 2013
- Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patientsBritish Journal of Cancer, 2012
- Enhanced Expression of Fibroblast Growth Factor Receptor 2 IIIc Promotes Human Pancreatic Cancer Cell ProliferationThe American Journal of Pathology, 2012
- STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH+/CD133+ stem cell-like human colon cancer cellsBiochemical and Biophysical Research Communications, 2011
- An automated cell-counting algorithm for fluorescently-stained cells in migration assaysBiological Procedures Online, 2011
- An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular PhenotypePLOS Genetics, 2011
- TGF‐β regulates isoform switching of FGF receptors and epithelial–mesenchymal transitionThe EMBO Journal, 2011
- A Complex Role for FGF-2 in Self-Renewal, Survival, and Adhesion of Human Embryonic Stem CellsStem Cells, 2009
- Vascular Proliferation Is Important for Clinical Progress of Endometrial CancerCancer Research, 2006